{"id":1617,"date":"2024-02-09T20:11:07","date_gmt":"2024-02-09T20:11:07","guid":{"rendered":"https:\/\/diarisanitat.cat\/recerca-en-salut\/?p=1617"},"modified":"2024-07-08T15:15:16","modified_gmt":"2024-07-08T15:15:16","slug":"la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson","status":"publish","type":"post","link":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2024\/02\/09\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\/","title":{"rendered":"La investigaci\u00f3 d\u2019un f\u00e0rmac contra el c\u00e0ncer permet evidenciar el seu potencial terap\u00e8utic tamb\u00e9 per al Parkinson"},"content":{"rendered":"<header>\n<div class=\"subtitle\">\n<p><strong>Investigadors de l\u2019IDIBELL, l\u2019ICO, l\u2019Institut de Qu\u00edmica Avan\u00e7ada de Catalunya i el CSIC han vist que un subproducte d\u2019aquest medicament anticancer\u00f3s redueix l\u2019acumulaci\u00f3 d\u2019una prote\u00efna dels cossos del Lewy, indicadors de la malaltia neurodegenerativa.<\/strong><\/p>\n<\/div>\n<\/header>\n<div class=\"entry-content\">\n<div class=\"code-block code-block-14\">\n<div>\n<p>Les infinites dianes de recerca dels investigadors al laboratori, endinsant la seva observaci\u00f3 en els gens i les c\u00e8l\u00b7lules per a estudiar-ne la composici\u00f3, comportament, interacci\u00f3 i evoluci\u00f3, acaben esdevenint vasos comunicants del saber global. Per aix\u00f2 \u00e9s important la publicaci\u00f3 dels resultats de les recerques en revistes d\u2019\u00e0mbit internacional, perqu\u00e8 il\u00b7luminen, complementen i enriqueixen o inspiren noves indagacions.<\/p>\n<p>A Barcelona, l\u2019estudi d\u2019un medicament usat en quimioter\u00e0pia del c\u00e0ncer d\u2019ovari, de mama i, m\u00e9s recentment, del c\u00e0ncer de pr\u00f2stata \u2013Rucaparib\u2013 ha obert una via d\u2019investigaci\u00f3 esperan\u00e7adora per als pacients de Parkinson. En concret, la recerca ha posat el focus en el producte metab\u00f2lic del f\u00e0rmac en q\u00fcesti\u00f3, una mena de subproducte que vindria a ser el residu d\u2019all\u00f2 que queda un cop el medicament fa la seva funci\u00f3, i que el mateix organisme processa per a la seva eliminaci\u00f3. Doncs b\u00e9, la recerca ha perm\u00e8s constatar que aquesta part residual tamb\u00e9 pot tenir la seva pr\u00f2pia funci\u00f3 en l\u2019actuaci\u00f3 amb el mateix c\u00e0ncer \u2013en concret ho han vist en el de pr\u00f2stata\u2013. Per\u00f2, a m\u00e9s, els investigadors han comprovat que aquest subproducte del f\u00e0rmac (M324) redueix l\u2019acumulaci\u00f3 de la prote\u00efna \u03b1-sinucle\u00efna, que \u00e9s un component important dels cossos de Lewy, subst\u00e0ncies dins de les neurones cerebrals que s\u00f3n indicadors (micromarcadors) de la malaltia de Parkinson.<\/p>\n<p>\u00c9s a dir, cercant l\u2019optimitzaci\u00f3 del f\u00e0rmac prescrit a certs pacients de c\u00e0ncer, i amb ell la metabolitzaci\u00f3 d\u2019aquest un cop actua, s\u2019ha donat llum verda a la recerca sobre un possible tractament de la malaltia neurodegenerativa del Parkinson. Aquesta patologia es caracteritza per un trastorn del moviment, i en la qual les neurones no produeixen les quantitats suficients del neurotransmissor dopamina.<\/p>\n<p>L\u2019estudi ha estat liderat pels investigadors Albert A. Antolin, del programa Oncobell de l\u2019Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Bellvitge (<a href=\"https:\/\/idibell.cat\/\">IDIBELL<\/a>) i ProCure de l\u2019Institut Catal\u00e0 d\u2019Oncologia (<a href=\"https:\/\/ico.gencat.cat\/ca\/inici\">ICO<\/a>), i Amadeu Llebaria, de l\u2019Institut de Qu\u00edmica Avan\u00e7ada de Catalunya (<a href=\"https:\/\/www.iqac.csic.es\/ca\/\">IQAC-CSIC<\/a>). I els resultats del seu treball l\u2019han publicat ja a la revista\u00a0<em><a href=\"https:\/\/www.cell.com\/cell-chemical-biology\/home\">Cell Chemical Biology<\/a>.<\/em><\/p>\n<p>Segons expliquen els autors de la investigaci\u00f3, els f\u00e0rmacs, un cop entren dins de l\u2019organisme, a banda de realitzar la seva funci\u00f3 terap\u00e8utica, es transformen bioqu\u00edmicament per acci\u00f3 de la maquin\u00e0ria metab\u00f2lica, proc\u00e9s que en facilita l\u2019expulsi\u00f3. Aquesta biotransformaci\u00f3 t\u00e9 com a resultat una desaparici\u00f3 gradual del f\u00e0rmac, que es va convertint en els seus metab\u00f2lits. Aquests, alhora, poden assolir altes concentracions en l\u2019organisme i mostrar, tamb\u00e9, una activitat biol\u00f2gica que pot ser diferent de la del f\u00e0rmac original. \u00c9s a dir, els metab\u00f2lits i el f\u00e0rmac coexisteixen a l\u2019organisme, i poden provocar efectes diferents dels obtinguts amb les mol\u00e8cules individuals.<\/p>\n<h3>Medicina de precisi\u00f3<\/h3>\n<p>En resum, l\u2019estudi apunta vers una nova perspectiva conceptual en farmacologia: la que considera el metabolisme dels f\u00e0rmacs no com un proc\u00e9s indesitjable que degrada i elimina la mol\u00e8cula terap\u00e8utica de l\u2019organisme, sin\u00f3 que pot tenir avantatges potencials des del punt de vista terap\u00e8utic. En conseq\u00fc\u00e8ncia, el treball destaca la import\u00e0ncia de caracteritzar l\u2019activitat dels metab\u00f2lits dels f\u00e0rmacs per comprendre de manera integral la seva resposta cl\u00ednica i aplicar-la en la medicina de precisi\u00f3. Aquest tipus de medicina \u00e9s la que t\u00e9 en compte la gen\u00e8tica, el context ambiental i els h\u00e0bits de cada persona. S\u00f3n aquestes particularitats de cadasc\u00fa que expliquen molts cops que la reacci\u00f3 a un f\u00e0rmac no sigui la mateixa que en la resta, i que el seu organisme se\u2019n benefici\u00ef m\u00e9s o menys.<\/p>\n<p>En benefici d\u2019aquesta medicina de precisi\u00f3, l\u2019investigador Albert Antolin ha enfocat la seva recerca durant molts anys a entendre el funcionament dels f\u00e0rmacs, per fer-los servir millor en els tractaments m\u00e9s precisos i personalitzats. \u201cLa nostra hip\u00f2tesi \u00e9s que els metab\u00f2lits \u2013tot all\u00f2 que es despr\u00e8n del principi actiu del f\u00e0rmac\u2013 potser fan altres coses diferents del f\u00e0rmac original i potser es podrien aprofitar per a altres activitats beneficioses\u201d, explica Antolin.<\/p>\n<p>En concret, en aquesta investigaci\u00f3, la sin\u00e8rgia de c\u00e0ncer i Parkinson va facilitar-la la proximitat de models indu\u00efts de c\u00e8l\u00b7lules mare per a l\u2019estudi del Parkinson que fa al mateix IDIBELL la investigadora Antonella Consiglio. Tamb\u00e9 han comptat amb la col\u00b7laboraci\u00f3 dels grups de l\u2019IDIBELL i de l\u2019ICO liderats per Miquel \u00c0ngel Pujana, \u00c1lvaro Ayt\u00e9s i la UB.<\/p>\n<p>Antolin comenta que \u201cgr\u00e0cies a m\u00e8todes computacionals i experimentals hem pogut caracteritzar d\u2019una manera integral, i per primera vegada, la farmacologia de la mol\u00e8cula M324\u201d. Albert Antolin ha estat guardonat recentment amb una ajuda Junior Leader de la Fundaci\u00f3 \u201cla Caixa\u201d. El primer autor del treball, Huabin Hu, ha fet una predicci\u00f3\u00a0 exhaustiva de l\u2019activitat diferencial del f\u00e0rmac original i del seu producte, que es tradueix en espectres diferents del patr\u00f3 de fosforil\u00b7laci\u00f3 de prote\u00efnes cel\u00b7lulars. Carme Serra, del grup MCS del IQAC-CSIC, ha sintetitzat el metab\u00f2lit M324, la qual cosa ha perm\u00e8s verificar experimentalment, en assaigs biol\u00f2gics i cel\u00b7lulars, la predicci\u00f3 computacional. Els resultats obtinguts podrien tenir implicacions en el tractament cl\u00ednic amb Rucaparib i, alhora, obren noves oportunitats de descobriment de f\u00e0rmacs.<\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Investigadors de l\u2019IDIBELL, l\u2019ICO, l\u2019Institut de Qu\u00edmica Avan\u00e7ada de Catalunya i el CSIC han vist que un subproducte d\u2019aquest medicament anticancer\u00f3s redueix l\u2019acumulaci\u00f3 d\u2019una prote\u00efna dels cossos del Lewy, indicadors de la malaltia neurodegenerativa. Les infinites dianes de recerca dels investigadors al laboratori, endinsant la seva observaci\u00f3 en els gens i les c\u00e8l\u00b7lules per a<\/p>\n","protected":false},"author":16,"featured_media":1618,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[126],"tags":[209,207],"tipo":[],"class_list":{"0":"post-1617","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-recerca","8":"tag-parkinson","9":"tag-recerca"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>La investigaci\u00f3 d\u2019un f\u00e0rmac contra el c\u00e0ncer permet evidenciar el seu potencial terap\u00e8utic tamb\u00e9 per al Parkinson - Recerca en salut<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2024\/02\/09\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La investigaci\u00f3 d\u2019un f\u00e0rmac contra el c\u00e0ncer permet evidenciar el seu potencial terap\u00e8utic tamb\u00e9 per al Parkinson - Recerca en salut\" \/>\n<meta property=\"og:description\" content=\"Investigadors de l\u2019IDIBELL, l\u2019ICO, l\u2019Institut de Qu\u00edmica Avan\u00e7ada de Catalunya i el CSIC han vist que un subproducte d\u2019aquest medicament anticancer\u00f3s redueix l\u2019acumulaci\u00f3 d\u2019una prote\u00efna dels cossos del Lewy, indicadors de la malaltia neurodegenerativa. Les infinites dianes de recerca dels investigadors al laboratori, endinsant la seva observaci\u00f3 en els gens i les c\u00e8l\u00b7lules per a\" \/>\n<meta property=\"og:url\" content=\"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2024\/02\/09\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\/\" \/>\n<meta property=\"og:site_name\" content=\"Recerca en salut\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-09T20:11:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-08T15:15:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-content\/uploads\/sites\/4\/2024\/02\/GettyImages-1832921718-1.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2380\" \/>\n\t<meta property=\"og:image:height\" content=\"1259\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Carme Escales\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Carme Escales\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2024\\\/02\\\/09\\\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2024\\\/02\\\/09\\\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\\\/\"},\"author\":{\"name\":\"Carme Escales\",\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/#\\\/schema\\\/person\\\/9080795ef06d370257b1c8e7967c8de8\"},\"headline\":\"La investigaci\u00f3 d\u2019un f\u00e0rmac contra el c\u00e0ncer permet evidenciar el seu potencial terap\u00e8utic tamb\u00e9 per al Parkinson\",\"datePublished\":\"2024-02-09T20:11:07+00:00\",\"dateModified\":\"2024-07-08T15:15:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2024\\\/02\\\/09\\\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\\\/\"},\"wordCount\":994,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2024\\\/02\\\/09\\\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/wp-content\\\/uploads\\\/sites\\\/4\\\/2024\\\/02\\\/GettyImages-1832921718-1.jpeg\",\"keywords\":[\"Parkinson\",\"recerca\"],\"articleSection\":[\"Recerca\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2024\\\/02\\\/09\\\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2024\\\/02\\\/09\\\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\\\/\",\"url\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2024\\\/02\\\/09\\\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\\\/\",\"name\":\"La investigaci\u00f3 d\u2019un f\u00e0rmac contra el c\u00e0ncer permet evidenciar el seu potencial terap\u00e8utic tamb\u00e9 per al Parkinson - Recerca en salut\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2024\\\/02\\\/09\\\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2024\\\/02\\\/09\\\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/wp-content\\\/uploads\\\/sites\\\/4\\\/2024\\\/02\\\/GettyImages-1832921718-1.jpeg\",\"datePublished\":\"2024-02-09T20:11:07+00:00\",\"dateModified\":\"2024-07-08T15:15:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/#\\\/schema\\\/person\\\/9080795ef06d370257b1c8e7967c8de8\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2024\\\/02\\\/09\\\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2024\\\/02\\\/09\\\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2024\\\/02\\\/09\\\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\\\/#primaryimage\",\"url\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/wp-content\\\/uploads\\\/sites\\\/4\\\/2024\\\/02\\\/GettyImages-1832921718-1.jpeg\",\"contentUrl\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/wp-content\\\/uploads\\\/sites\\\/4\\\/2024\\\/02\\\/GettyImages-1832921718-1.jpeg\",\"width\":2380,\"height\":1259,\"caption\":\"Pills, tablets and capsules on world map with charts blue background. International pharmaceutical research concept.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/2024\\\/02\\\/09\\\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La investigaci\u00f3 d\u2019un f\u00e0rmac contra el c\u00e0ncer permet evidenciar el seu potencial terap\u00e8utic tamb\u00e9 per al Parkinson\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/#website\",\"url\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/\",\"name\":\"Recerca en salut\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/#\\\/schema\\\/person\\\/9080795ef06d370257b1c8e7967c8de8\",\"name\":\"Carme Escales\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/diarisanitat.cat\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/carme-escales_avatar-96x96.png\",\"url\":\"https:\\\/\\\/diarisanitat.cat\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/carme-escales_avatar-96x96.png\",\"contentUrl\":\"https:\\\/\\\/diarisanitat.cat\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/carme-escales_avatar-96x96.png\",\"caption\":\"Carme Escales\"},\"description\":\"Periodista amb m\u00e9s de 20 anys d'experi\u00e8ncia. Especialitzada en posar a l'abast de tothom el llenguatge de la medicina, la ci\u00e8ncia i la salut.\",\"url\":\"https:\\\/\\\/diarisanitat.cat\\\/recerca-en-salut\\\/blog\\\/author\\\/carmeescales\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La investigaci\u00f3 d\u2019un f\u00e0rmac contra el c\u00e0ncer permet evidenciar el seu potencial terap\u00e8utic tamb\u00e9 per al Parkinson - Recerca en salut","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2024\/02\/09\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\/","og_locale":"es_ES","og_type":"article","og_title":"La investigaci\u00f3 d\u2019un f\u00e0rmac contra el c\u00e0ncer permet evidenciar el seu potencial terap\u00e8utic tamb\u00e9 per al Parkinson - Recerca en salut","og_description":"Investigadors de l\u2019IDIBELL, l\u2019ICO, l\u2019Institut de Qu\u00edmica Avan\u00e7ada de Catalunya i el CSIC han vist que un subproducte d\u2019aquest medicament anticancer\u00f3s redueix l\u2019acumulaci\u00f3 d\u2019una prote\u00efna dels cossos del Lewy, indicadors de la malaltia neurodegenerativa. Les infinites dianes de recerca dels investigadors al laboratori, endinsant la seva observaci\u00f3 en els gens i les c\u00e8l\u00b7lules per a","og_url":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2024\/02\/09\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\/","og_site_name":"Recerca en salut","article_published_time":"2024-02-09T20:11:07+00:00","article_modified_time":"2024-07-08T15:15:16+00:00","og_image":[{"width":2380,"height":1259,"url":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-content\/uploads\/sites\/4\/2024\/02\/GettyImages-1832921718-1.jpeg","type":"image\/jpeg"}],"author":"Carme Escales","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Carme Escales","Tiempo de lectura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2024\/02\/09\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\/#article","isPartOf":{"@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2024\/02\/09\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\/"},"author":{"name":"Carme Escales","@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/#\/schema\/person\/9080795ef06d370257b1c8e7967c8de8"},"headline":"La investigaci\u00f3 d\u2019un f\u00e0rmac contra el c\u00e0ncer permet evidenciar el seu potencial terap\u00e8utic tamb\u00e9 per al Parkinson","datePublished":"2024-02-09T20:11:07+00:00","dateModified":"2024-07-08T15:15:16+00:00","mainEntityOfPage":{"@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2024\/02\/09\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\/"},"wordCount":994,"commentCount":0,"image":{"@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2024\/02\/09\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\/#primaryimage"},"thumbnailUrl":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-content\/uploads\/sites\/4\/2024\/02\/GettyImages-1832921718-1.jpeg","keywords":["Parkinson","recerca"],"articleSection":["Recerca"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2024\/02\/09\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2024\/02\/09\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\/","url":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2024\/02\/09\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\/","name":"La investigaci\u00f3 d\u2019un f\u00e0rmac contra el c\u00e0ncer permet evidenciar el seu potencial terap\u00e8utic tamb\u00e9 per al Parkinson - Recerca en salut","isPartOf":{"@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/#website"},"primaryImageOfPage":{"@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2024\/02\/09\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\/#primaryimage"},"image":{"@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2024\/02\/09\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\/#primaryimage"},"thumbnailUrl":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-content\/uploads\/sites\/4\/2024\/02\/GettyImages-1832921718-1.jpeg","datePublished":"2024-02-09T20:11:07+00:00","dateModified":"2024-07-08T15:15:16+00:00","author":{"@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/#\/schema\/person\/9080795ef06d370257b1c8e7967c8de8"},"breadcrumb":{"@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2024\/02\/09\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2024\/02\/09\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2024\/02\/09\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\/#primaryimage","url":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-content\/uploads\/sites\/4\/2024\/02\/GettyImages-1832921718-1.jpeg","contentUrl":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-content\/uploads\/sites\/4\/2024\/02\/GettyImages-1832921718-1.jpeg","width":2380,"height":1259,"caption":"Pills, tablets and capsules on world map with charts blue background. International pharmaceutical research concept."},{"@type":"BreadcrumbList","@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/2024\/02\/09\/la-investigacio-dun-farmac-contra-el-cancer-permet-evidenciar-el-seu-potencial-terapeutic-tambe-per-al-parkinson\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/diarisanitat.cat\/recerca-en-salut\/"},{"@type":"ListItem","position":2,"name":"La investigaci\u00f3 d\u2019un f\u00e0rmac contra el c\u00e0ncer permet evidenciar el seu potencial terap\u00e8utic tamb\u00e9 per al Parkinson"}]},{"@type":"WebSite","@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/#website","url":"https:\/\/diarisanitat.cat\/recerca-en-salut\/","name":"Recerca en salut","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/diarisanitat.cat\/recerca-en-salut\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/diarisanitat.cat\/recerca-en-salut\/#\/schema\/person\/9080795ef06d370257b1c8e7967c8de8","name":"Carme Escales","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/diarisanitat.cat\/wp-content\/uploads\/2024\/11\/carme-escales_avatar-96x96.png","url":"https:\/\/diarisanitat.cat\/wp-content\/uploads\/2024\/11\/carme-escales_avatar-96x96.png","contentUrl":"https:\/\/diarisanitat.cat\/wp-content\/uploads\/2024\/11\/carme-escales_avatar-96x96.png","caption":"Carme Escales"},"description":"Periodista amb m\u00e9s de 20 anys d'experi\u00e8ncia. Especialitzada en posar a l'abast de tothom el llenguatge de la medicina, la ci\u00e8ncia i la salut.","url":"https:\/\/diarisanitat.cat\/recerca-en-salut\/blog\/author\/carmeescales\/"}]}},"_links":{"self":[{"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/posts\/1617","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/comments?post=1617"}],"version-history":[{"count":1,"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/posts\/1617\/revisions"}],"predecessor-version":[{"id":38075,"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/posts\/1617\/revisions\/38075"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/media\/1618"}],"wp:attachment":[{"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/media?parent=1617"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/categories?post=1617"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/tags?post=1617"},{"taxonomy":"tipo","embeddable":true,"href":"https:\/\/diarisanitat.cat\/recerca-en-salut\/wp-json\/wp\/v2\/tipo?post=1617"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}